I'm looking for a job. I exported this list from FewerJobs.com - a curated job board. Please: 1. Rank these jobs by fit for me, given my resume / skills. 2. Highlight the top 5 with a one-sentence rationale each. 3. Flag any concerns, including benefit values without source-backed evidence. 4. Suggest one or two filter changes I could make on FewerJobs to find more good matches. Filters I applied: - q: Summit Therapeutics - quality_floor: default - match_401k_strict: true - parental_strict: true - non_birth_strict: true - pto_strict: true - include_older: false - apply_url_verified: false - page: 1 - per_page: 100 - sort: relevance Jobs (100 total): --- TITLE: Corporate Counsel, Clinical Contracts EMPLOYER: Summit Therapeutics LOCATION: Remote (US) (remote) SALARY: $158K-$185K POSTED: 2026-05-27 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4259982009 EXCERPT: Corporate Counsel, Clinical Contracts Remote (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an --- TITLE: Director, Safety Physician EMPLOYER: Summit Therapeutics LOCATION: Remote (UK) (remote) SALARY: Not disclosed POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174771009 EXCERPT: Director, Safety Physician Remote (UK) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational --- TITLE: Sr. Commercial Attorney, Transactions EMPLOYER: Summit Therapeutics LOCATION: Remote (US) (remote) SALARY: $217K-$271K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174612009 EXCERPT: Sr. Commercial Attorney, Transactions Remote (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an --- TITLE: Senior Manager, Regulatory Affairs EMPLOYER: Summit Therapeutics LOCATION: Oxford (UK) (unspecified) SALARY: EUR 80K-95K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174479009 EXCERPT: Senior Manager, Regulatory Affairs Oxford (UK) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an --- TITLE: Clinical Trial Manager EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, CA (US) (unspecified) SALARY: $140K-$150K POSTED: 2026-04-16 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4223217009 EXCERPT: Clinical Trial Manager Palo Alto, CA (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is --- TITLE: Director, Clinical Scientist EMPLOYER: Summit Therapeutics LOCATION: Princeton, NJ (US) (unspecified) SALARY: $200K-$250K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174773009 EXCERPT: Director, Clinical Scientist Princeton, NJ (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an --- TITLE: Clinical Supplies Manager EMPLOYER: Summit Therapeutics LOCATION: Remote (remote) SALARY: $120K-$145K POSTED: 2026-04-01 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4205206009 EXCERPT: Clinical Supplies Manager Remote About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy --- TITLE: Vice President, US Marketing EMPLOYER: Summit Therapeutics LOCATION: Princeton, NJ (US) (unspecified) SALARY: $315K-$350K POSTED: 2026-05-19 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4252097009 EXCERPT: Vice President, US Marketing Princeton, NJ (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is --- TITLE: Accounting Manager, R&D (Non-Clinical) EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, CA (US) (unspecified) SALARY: $140K-$160K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174588009 EXCERPT: Accounting Manager, R&D (Non-Clinical) Palo Alto, CA (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab --- TITLE: Director, Portfolio Strategy EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, CA (US) (unspecified) SALARY: $200K-$250K POSTED: 2026-06-05 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4274498009 EXCERPT: Director, Portfolio Strategy Palo Alto, CA (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is --- TITLE: Senior Medical Science Liaison (KS, MO, OK, AR) EMPLOYER: Summit Therapeutics LOCATION: Kansas City, Missouri, United States (unspecified) SALARY: $200K-$235K POSTED: 2026-05-22 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4256943009 EXCERPT: Senior Medical Science Liaison (KS, MO, OK, AR) Kansas City, Missouri, United States About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared --- TITLE: Executive Director, US Market Access Strategy EMPLOYER: Summit Therapeutics LOCATION: Princeton, NJ (unspecified) SALARY: $245K-$307K POSTED: 2026-04-17 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4224815009 EXCERPT: Executive Director, US Market Access Strategy Princeton, NJ About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab --- TITLE: Director, Biostatistics EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, California, United States (unspecified) SALARY: $203K-$253K POSTED: 2026-03-18 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4183442009 EXCERPT: Director, Biostatistics Palo Alto, California, United States About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is --- TITLE: Senior Manager, Clinical Site Partner (Germany) EMPLOYER: Summit Therapeutics LOCATION: Remote-Field (Germany) (remote) SALARY: Not disclosed POSTED: 2026-04-24 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4229849009 EXCERPT: Senior Manager, Clinical Site Partner (Germany) Remote-Field (Germany) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab --- TITLE: Associate Director, Biostatistics EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, California, United States (unspecified) SALARY: $190K-$210K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174817009 EXCERPT: Associate Director, Biostatistics Palo Alto, California, United States About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab --- TITLE: Senior Medical Science Liaison (ND, SD, MN, IA, MO, NE) EMPLOYER: Summit Therapeutics LOCATION: Remote-Field (US) (remote) SALARY: $200K-$235K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174514009 EXCERPT: Senior Medical Science Liaison (ND, SD, MN, IA, MO, NE) Remote-Field (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with --- TITLE: Lead, Regional Medical Science Director EMPLOYER: Summit Therapeutics LOCATION: Raleigh, North Carolina, United States (unspecified) SALARY: $250K-$270K POSTED: 2026-05-22 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4257505009 EXCERPT: Lead, Regional Medical Science Director Raleigh, North Carolina, United States About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus --- TITLE: Senior Medical Science Liaison (TX & NM) EMPLOYER: Summit Therapeutics LOCATION: Dallas, Texas, United States (unspecified) SALARY: $200K-$235K POSTED: 2026-05-22 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4256945009 EXCERPT: Senior Medical Science Liaison (TX & NM) Dallas, Texas, United States About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab --- TITLE: Associate Director, Regulatory CMC EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, CA (US) (unspecified) SALARY: $194K-$199K POSTED: 2026-05-05 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4239849009 EXCERPT: Associate Director, Regulatory CMC Palo Alto, CA (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab --- TITLE: Senior Medical Science Liaison(NY & NJ) EMPLOYER: Summit Therapeutics LOCATION: Brooklyn, New York, United States (unspecified) SALARY: $200K-$235K POSTED: 2026-05-22 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4256934009 EXCERPT: Senior Medical Science Liaison(NY & NJ) Brooklyn, New York, United States About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab --- TITLE: Senior Director of Technical QA (GMP) EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, CA (US) (unspecified) SALARY: $217K-$271K POSTED: 2026-05-20 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4252108009 EXCERPT: Senior Director of Technical QA (GMP) Palo Alto, CA (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus --- TITLE: Executive Director, Regulatory Affairs – Global Regulatory Leader EMPLOYER: Summit Therapeutics LOCATION: (Remote US) (remote) SALARY: $231K-$285K POSTED: 2026-06-05 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4274378009 EXCERPT: Executive Director, Regulatory Affairs – Global Regulatory Leader (Remote US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus --- TITLE: Senior Director, Sales Operations (Oncology) EMPLOYER: Summit Therapeutics LOCATION: Princeton, NJ (US) (unspecified) SALARY: $231K-$285K POSTED: 2026-03-09 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174529009 EXCERPT: Senior Director, Sales Operations (Oncology) Princeton, NJ (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab --- TITLE: Senior Principal Engineer/Associate Director, Drug Product MSAT EMPLOYER: Summit Therapeutics LOCATION: Princeton, NJ (unspecified) SALARY: $180K-$195K POSTED: 2026-04-27 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4232801009 EXCERPT: Senior Principal Engineer/Associate Director, Drug Product MSAT Princeton, NJ About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. --- TITLE: Associate Director, Clinical Supplies-Global Planning & Operations EMPLOYER: Summit Therapeutics LOCATION: Palo Alto, CA (US) (unspecified) SALARY: $175K-$200K POSTED: 2026-05-26 APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4252276009 EXCERPT: Associate Director, Clinical Supplies-Global Planning & Operations Palo Alto, CA (US) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab --- TITLE: Senior Director/Vice President, Patient, HCP, and Payer Marketing EMPLOYER: Click Therapeutics LOCATION: New York, NY (unspecified) SALARY: $180K-$280K POSTED: 2026-04-21 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8515720002 EXCERPT: Senior Director/Vice President, Patient, HCP, and Payer Marketing New York, NY Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As a Senior Director / Vice President of HCP and Payer Marketing, you will shape the overall marketing strategy for near-term launch products and build a best in class marketing organization to execute that vision. You and your team will define the brand strategy and create the narrative and materials that drive behavior --- TITLE: OnSite Specialist - Summit, NJ EMPLOYER: Stryker Corporation LOCATION: Summit, New Jersey (onsite) SALARY: Not disclosed POSTED: 2026-05-27 PARENTAL_LEAVE_WEEKS: 6 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://stryker.wd1.myworkdayjobs.com/StrykerCareers/job/Summit-New-Jersey/OnSite-Specialist---Summit--NJ_R566375 EXCERPT: OnSite Specialist - Summit, NJ Summit, New Jersey posted: Posted 16 Days Ago --- TITLE: Senior Director/Vice President, Market Access EMPLOYER: Click Therapeutics LOCATION: New York, NY (unspecified) SALARY: $180K-$280K POSTED: 2026-04-21 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8515744002 EXCERPT: Senior Director/Vice President, Market Access New York, NY Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As a Senior Director / Vice President of Market Access, you will be the backbone of the commercial organization. You will design the financial architecture of the product, shape the external policy and regulatory environments to support PDTs, and ensure long term viability of the PDT category. The role reports to the Chief Commercial Officer and --- TITLE: Store Manager II - Summit EMPLOYER: Toronto-Dominion Bank LOCATION: Summit, New Jersey (unspecified) SALARY: Not disclosed POSTED: 2026-06-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://td.wd3.myworkdayjobs.com/TD_Bank_Careers/job/Summit-New-Jersey/Store-Manager-II---Summit_R_1492866 EXCERPT: Store Manager II - Summit Summit, New Jersey posted: Posted 8 Days Ago --- TITLE: Assistant Store Manager - Summit EMPLOYER: Toronto-Dominion Bank LOCATION: Summit, New Jersey (unspecified) SALARY: Not disclosed POSTED: 2026-06-11 K401_MATCH: yes (not source-backed) APPLY_URL: https://td.wd3.myworkdayjobs.com/TD_Bank_Careers/job/Summit-New-Jersey/Assistant-Store-Manager---Summit_R_1494238 EXCERPT: Assistant Store Manager - Summit Summit, New Jersey posted: Posted Yesterday --- TITLE: Senior Director/VP, Medical Affairs EMPLOYER: Click Therapeutics LOCATION: New York, NY, Boston, MA or Remote (remote) SALARY: $180K-$280K POSTED: 2026-04-29 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8525471002 EXCERPT: Senior Director/VP, Medical Affairs New York, NY, Boston, MA or Remote Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As the Senior Director / Vice President of Medical Affairs, you will be the scientific heartbeat of the organization. You will act as the scientific authority for CT-155. This team generates the evidence (RWE/OLE) needed to prove clinical value and economic impact, supplying the "raw material" that Marketing and Access teams leverage. The --- TITLE: Patient and Community Educators - Southeast EMPLOYER: Cogent Biosciences Inc LOCATION: Remote, United States (remote) SALARY: $190K-$225K POSTED: 2026-04-07 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4210405009 EXCERPT: Patient and Community Educators - Southeast Remote, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Patient and Community Educator (PACE) serves as a trusted resource for individuals living with Systemic Mastocytosis (SM) and Gastrointestinal Stromal Tumor (GIST) , as well as their caregivers and community members. Reporting to the Director, Patient and Community Educators, this field-based role is responsible for delivering clear, compassionate, and compliant disease and treatment education through live and virtual engagements. The PACE team will play a critical role in empowering patients and caregivers with knowledge that helps them better understand their condition, navigate their treatment journey, and engage more confidently in conversations with their healthcare teams. This role requires a unique combination of clinical fluency, emotional intelligence, and communication expertise. The ideal candidate is --- TITLE: Process Engineer, Greensboro Brown Summit Plant EMPLOYER: The Procter & Gamble Company LOCATION: GREENSBORO BROWN SUMMIT PLANT (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 PARENTAL_LEAVE_WEEKS: 8 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 8 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://pg.wd5.myworkdayjobs.com/1000/job/GREENSBORO-BROWN-SUMMIT-PLANT/Process-Engineer--Greensboro-Brown-Summit-Plant_R000150717 EXCERPT: Process Engineer, Greensboro Brown Summit Plant GREENSBORO BROWN SUMMIT PLANT posted: Posted 30+ Days Ago --- TITLE: Child Care Teachers in Summit NJ EMPLOYER: Bright Horizons LOCATION: Summit, New Jersey, United States of America (unspecified) SALARY: Not disclosed POSTED: 2026-03-05 K401_MATCH: yes (not source-backed) APPLY_URL: https://brighthorizons.wd5.myworkdayjobs.com/External-NorthAmerica/job/Summit-NJ-07901/Child-Care-Teachers-in-Summit-NJ_JR-135835/apply EXCERPT: Child Care Teachers in Summit NJ Summit, New Jersey, United States of America Join our amazing team at Overlook Hospital- powered by Bright Horizons! The center address is 44 Upper Overlook Rd in Summit NJ. Grow your teaching career with Bright Horizons, where you can make a... --- TITLE: Join Our Talent Community EMPLOYER: Click Therapeutics LOCATION: New York, NY or Boston, MA (unspecified) SALARY: Not disclosed POSTED: 2024-12-16 APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/7776029002 EXCERPT: Join Our Talent Community New York, NY or Boston, MA Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About Our Talent Community: Don't see a perfect fit for your skills right now? We're constantly growing and adding new positions. Join our talent community to stay informed about upcoming opportunities that align with your unique background and experience. Be the first to know about exciting new roles! While joining our talent community doesn't constitute a formal --- TITLE: Senior Controls & Automation Engineer, Greensboro Brown Summit Plant EMPLOYER: The Procter & Gamble Company LOCATION: GREENSBORO BROWN SUMMIT PLANT (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 PARENTAL_LEAVE_WEEKS: 8 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 8 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://pg.wd5.myworkdayjobs.com/1000/job/GREENSBORO-BROWN-SUMMIT-PLANT/Senior-Controls---Automation-Engineer--Greensboro-Brown-Summit-Plant_R000147628 EXCERPT: Senior Controls & Automation Engineer, Greensboro Brown Summit Plant GREENSBORO BROWN SUMMIT PLANT posted: Posted 30+ Days Ago --- TITLE: Senior Director, Clinical Development EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $248K-$299K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5808053004 EXCERPT: Senior Director, Clinical Development Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! The Sr. Director, Clinical Development will play a key role in the design and execution of ongoing and new clinical studies and contribute to the clinical development plan for one or more programs. The position will successfully lead and/or serve as the clinical science representative on one or more clinical studies (US and/or global) to deliver high quality data for registration. The position requires the --- TITLE: Broista - Lees Summit, MO EMPLOYER: Dutch Bros Inc. LOCATION: Lees Summit, Missouri, United States of America (unspecified) SALARY: Not disclosed POSTED: 2026-02-06 K401_MATCH: yes (not source-backed) APPLY_URL: https://dutchbros.wd1.myworkdayjobs.com/DBShops/job/500-NW-Chipman-Rd-Lees-Summit-MO-64086/Broista---Lees-Summit--MO_REQ-12622/apply EXCERPT: Broista - Lees Summit, MO Lees Summit, Missouri, United States of America We are looking for a passionate individual to join our team as a Broista in Lee's Summit, MO. If you thrive in a fast-paced environment and love making connections with customers, this is the perfect opportunity for you to shine and make a difference one cup at a time! --- TITLE: Senior Director, Marketing EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $252K-$295K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5985751004 EXCERPT: Senior Director, Marketing Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key --- TITLE: Associate Director, Clinical Development EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $170K-$192K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5977186004 EXCERPT: Associate Director, Clinical Development Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! The Associate Director, Clinical Development plays a key role in the design and execution of ongoing and new clinical development studies. This position serves as the clinical science representative on one or more U.S. and/or global clinical studies and contributes to the delivery of high‑quality clinical data to support registration and launch. The role partners cross‑functionally with Clinical Operations, Clinical Pharmacology, Regulatory Affairs, Early Development, --- TITLE: Referral Admissions Coordinator EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-06-11 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Referral-Admissions-Coordinator_JR125122 EXCERPT: Referral Admissions Coordinator Summit Healthcare Mgmt posted: Posted Yesterday --- TITLE: Clinical Trial Leader EMPLOYER: Tango Therapeutics Inc LOCATION: Boston, MA (unspecified) SALARY: $160K-$241K POSTED: 2026-05-06 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/tangotherapeutics/jobs/7723892003 EXCERPT: Clinical Trial Leader Boston, MA Company Overview Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts. Summary We are seeking a Clinical Trial Leader (CTL) to lead cross-functional clinical trial teams (CTTs) in the execution of clinical trials of Tango's portfolio. This role will chair the CTT and represent the cross-functional team to internal governance bodies. The CTL will be an internal escalation point for other CTT members. In a fast-paced, small biotech environment, the CTL will operationally lead the set-up, conduct and reporting of clinical trials as per approved timelines, budget, regulatory requirements, and internal standards. This individual will play a key role in the execution and delivery of clinical trial objectives. The ideal candidate is highly collaborative, detail-oriented, and comfortable operating in a hands-on environment, with a focus on building scalable processes, tools, and best practices to support efficient and compliant clinical trial execution. Your role - Lead cross-functional Clinical Trial Team --- TITLE: Director of Talent Acquisition EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-29 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Director-of-Talent-Acquisition_JR125232 EXCERPT: Director of Talent Acquisition Summit Healthcare Mgmt posted: Posted 14 Days Ago --- TITLE: Director, Regulatory Strategy EMPLOYER: Rapport Therapeutics Inc LOCATION: 99 High Street, Suite 2100 , Boston, MA 02110 (unspecified) SALARY: $220K-$240K POSTED: 2026-01-24 APPLY_URL: https://www.rapportrx.com/careers-board/?gh_jid=5001273007 EXCERPT: Director, Regulatory Strategy 99 High Street, Suite 2100 , Boston, MA 02110 When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we're driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we're doing this with extraordinary science and awesome people (affectionately called Rapptors). Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder. The strength of Rapport comes from our Rapptors - who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you're as excited about this opportunity as we are! Your Impact: The Director of Regulatory Strategy will play a pivotal role in leading strategic regulatory initiatives for assigned drug development programs. Your Day-to-Day: - Create and implement innovative and effective regulatory strategies to support the development of Rapport global drug development programs - Provide regulatory expertise and advise to cross-functional team --- TITLE: Central Accounting Manager EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Central-Accounting-Manager_JR124535 EXCERPT: Central Accounting Manager Summit Healthcare Mgmt posted: Posted 30+ Days Ago --- TITLE: Executive Director, Commercial Supply Chain EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $238K-$310K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5848310004 EXCERPT: Executive Director, Commercial Supply Chain Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! Qualifications Bachelor's degree (or equivalent) in science or business with 15+ years of relevant experience in pharmaceutical supply chain, including specialty product launches Expertise in strategic global supply chain, commercial manufacturing, and supplier relationship management in a virtual environment Experience forming, developing, and leading a pharmaceutical commercial supply chain function ideally in a virtual environment Significant experience leading and influencing raw material, small molecule --- TITLE: Facility Director of Nursing EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Facility-Director-of-Nursing_JR123888 EXCERPT: Facility Director of Nursing Summit Healthcare Mgmt posted: Posted 30+ Days Ago --- TITLE: Lot Attendant - Aston Martin Summit EMPLOYER: AutoNation LOCATION: Summit, New Jersey, United States of America (unspecified) SALARY: Not disclosed POSTED: 2026-05-28 K401_MATCH: yes (not source-backed) APPLY_URL: https://autonation.wd5.myworkdayjobs.com/Careers/job/Aston-Martin-Summit/Lot-Attendant---Aston-Martin-Summit_JR2026141792/apply EXCERPT: Lot Attendant - Aston Martin Summit Summit, New Jersey, United States of America Embrace the role of a Lot Attendant at Aston Martin Summit! You'll assist with vehicle maintenance, inspection, and customer service while ensuring a clean and organized lot. If you have a valid driver's license, strong attention to detail, and enjoy working in a fast-paced environment, this is your opportunity to grow in the automotive industry. --- TITLE: Executive Director, Clinical Development EMPLOYER: Mineralys Therapeutics Inc LOCATION: US Remote (remote) SALARY: $340K-$370K POSTED: 2026-04-21 APPLY_URL: https://job-boards.greenhouse.io/mineralystherapeutics/jobs/5195429008 EXCERPT: Executive Director, Clinical Development US Remote “Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com . Follow Mineralys on LinkedIn , Twitter and Bluesky ” Mineralys is a fully remote company. Executive Director, Clinical Development The Executive Director, Clinical Development will serve as the clinical lead for development program(s) and play a critical role in advancing pivotal studies, regulatory strategy, and submission readiness. This physician leader will provide medical and scientific oversight across the program lifecycle, from protocol design and study execution through data interpretation, regulatory interactions, and launch preparation. This role requires a hands-on clinical development leader who thrives in a fast-paced biotech environment and can partner cross-functionally to drive high-quality execution with urgency. Key Responsibilities: Clinical Development Leadership - Serve as the clinical lead for one or more clinical programs, with responsibility for clinical trial design, execution oversight, and delivery of key milestones. - Lead development of clinical plans, protocols, amendments, , and related study documents. - Provide medical oversight for Phase 2/3 and/or registrational studies, ensuring patient safety, data integrity, and operational excellence. - Partner with Clinical Operations, Biostatistics, Data Management, Regulatory, and Safety to ensure efficient study execution and timely issue resolution. - Drive --- TITLE: Associate Clinical Sales Specialist (CS) - Minneapolis/Des Moines, IA EMPLOYER: Corcept Therapeutics LOCATION: Des Moines, Iowa, United States (unspecified) SALARY: $100K-$130K POSTED: 2026-04-01 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=5842117004 EXCERPT: Associate Clinical Sales Specialist (CS) - Minneapolis/Des Moines, IA Des Moines, Iowa, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Associate CS is accountable for implementing the sales strategies for approved products consistent with Corcept's compliance standards as well as all applicable legal requirements for those key targeted health care providers and hospital systems within an assigned territory. Responsibilities: - Build and develop professional relationships with influential high prescribers and thought leaders in the territory to enhance Corcept brand and product loyalty - Leverages expertise and knowledge of the therapeutic disease state, the marketplace, applicable competitors, industry, and cross-functional activities/plans to anticipate and effectively manage business opportunities and challenges - Develops and implements effective customer specific territory plans and communicates insights to internal stakeholders - Prioritizes time and effort to ensure optimal coverage of appropriate physician specialists based on opportunity and potential - Plan and participate in education programs and speaker dinner --- TITLE: National Continuing Care Coordinator - Behavioral Health EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-06-11 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/National-Continuing-Care-Coordinator---Behavioral-Health_JR125416 EXCERPT: National Continuing Care Coordinator - Behavioral Health Summit Healthcare Mgmt posted: Posted Yesterday --- TITLE: Associate Director, Commercial Strategy and Insights EMPLOYER: Maplight Therapeutics Inc LOCATION: Burlington, MA (unspecified) SALARY: $195K-$220K POSTED: 2026-05-22 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/maplighttherapeutics/jobs/5228687008 EXCERPT: Associate Director, Commercial Strategy and Insights Burlington, MA Who We Are: MapLight Therapeutics is a clinical stage biotech company that focuses on drug discovery for central nervous system disorders. We combine cutting-edge technologies including optogenetics, in vivo physiology, and spatial transcriptomics to identify novel drug targets and develop effective therapies to address psychiatric symptoms. What You'll Do: We are seeking a highly motivated Associate Director, Commercial Strategy and Insights to support the development and execution of commercial initiatives across our growing organization. This role will help build market research, forecasting, and competitive intelligence that inform launch planning, market opportunity assessments, and commercial strategy for our lead asset and broader pipeline. As the commercial function grows, the role is expected to evolve into a role on our Insights and Analytics team. The Associate Director will work closely with Commercial Leadership, Marketing, Market Access, Medical Affairs, Sales, Finance, Business Development, and Clinical teams to inform data-driven strategies that maximize product value and support long-term company growth. The ideal candidate combines analytical rigor, strategic thinking, and strong cross-functional collaboration within a fast-paced pre-commercial biotech environment. Responsibilities : - Support market research, forecasting and analytics workstreams that inform integrated commercial strategies for our lead asset and pipeline products. - Conduct market assessments, competitive analyses, and opportunity evaluations to inform strategic decision-making. - Partner with cross-functional teams to define product positioning, target customer segments, and value propositions. - Support commercial launch planning activities for new products and indications. - Identify commercial risks, opportunities, and mitigation --- TITLE: PRN Facility CFO- Behavioral Health EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-22 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/PRN-Facility-CFO--Behavioral-Health_JR125136 EXCERPT: PRN Facility CFO- Behavioral Health Summit Healthcare Mgmt posted: Posted 21 Days Ago --- TITLE: Associate Director, Biostatistics EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $184K-$209K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5848284004 EXCERPT: Associate Director, Biostatistics Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! As an Associate Director, Biostatistics this person will provide statistical support for pipeline compounds' clinical development, regulatory filing, and commercialization. Reporting to Vice President, Head of Biometrics and Data Science, the successful candidate will serve as the biostatistician for assigned clinical trials to provide statistical leadership from trial design, data analysis, to results interpretation and dissemination. This role will also provide statistical support to regulatory filing --- TITLE: Enterprise Account Manager - Behavioral Health EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-22 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Enterprise-Account-Manager---West_JR124919 EXCERPT: Enterprise Account Manager - Behavioral Health Summit Healthcare Mgmt posted: Posted 21 Days Ago --- TITLE: Executive Director, Clinical Program Management EMPLOYER: Maplight Therapeutics Inc LOCATION: Remote (remote) SALARY: $276K-$321K POSTED: 2026-05-26 APPLY_URL: https://job-boards.greenhouse.io/maplighttherapeutics/jobs/5230710008 EXCERPT: Executive Director, Clinical Program Management Remote Who We Are: MapLight Therapeutics is a clinical stage biotech company that focuses on drug discovery for central nervous system disorders. We combine cutting-edge technologies including optogenetics, in vivo physiology, and spatial transcriptomics to identify novel drug targets and develop effective therapies to address psychiatric symptoms. Who We Are: MapLight Therapeutics is a clinical stage biotech company that focuses on drug discovery for central nervous system disorders. We combine cutting-edge technologies including optogenetics, in vivo physiology, and spatial transcriptomics to identify novel drug targets and develop effective therapies to address psychiatric symptoms. What You'll Do: The Executive Director, Clinical Program Management provides leadership and direction across the MapLight clinical development portfolio, supporting programs across all stages of development. The role is accountable for oversight, functional leadership, and consistency of program management practices, strengthening the quality and effectiveness of program management across Clinical Development. This role reports to the Senior Vice President, Clinical Development and may have one or more direct reports. Responsibilities - Lead the Clinical Program Management function by defining standards, best practices, and continuous improvement initiatives, and by developing the team through coaching, feedback, and role modeling to strengthen Program Management as a discipline within the organization. - Be accountable for Clinical Program Management effectiveness across the clinical development portfolio. - Align with leadership to deliver corporate and departmental goals and initiatives. - Partner with Clinical Leads and cross-functional teams on program planning, deliverables, and timelines, supporting effective execution across the portfolio. --- TITLE: Strategic Account Director - Behavioral Health EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-22 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Strategic-Account-Director---Behavioral-Health_JR124918 EXCERPT: Strategic Account Director - Behavioral Health Summit Healthcare Mgmt posted: Posted 21 Days Ago --- TITLE: Senior Clinical Trial Associate EMPLOYER: Rapport Therapeutics Inc LOCATION: 99 High Street, Suite 2100 , Boston, MA 02110 (unspecified) SALARY: $90K-$110K POSTED: 2026-04-22 APPLY_URL: https://www.rapportrx.com/careers-board/?gh_jid=5001441007 EXCERPT: Senior Clinical Trial Associate 99 High Street, Suite 2100 , Boston, MA 02110 When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we're driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we're doing this with extraordinary science and awesome people (affectionately called Rapptors). Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder. The strength of Rapport comes from our Rapptors - who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you're as excited about this opportunity as we are! Your impact: As a Senior Clinical Trial Associate, you'll be a key player in keeping our clinical studies on track-managing the details, supporting the team, and helping bring innovative treatments to patients Your day-to-day: - Coordinates and tracks the distribution and subsequent retrieval of clinical documents, including but not limited to --- TITLE: Chief Quality & Patient Safety Officer - Behavioral Health EMPLOYER: Summit BHC LOCATION: Summit Healthcare Mgmt (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Summit-Healthcare-Mgmt/Chief-Quality---Patient-Safety-Officer---Behavioral-Health_JR124207 EXCERPT: Chief Quality & Patient Safety Officer - Behavioral Health Summit Healthcare Mgmt posted: Posted 30+ Days Ago --- TITLE: Manager, Market Intelligence and Strategy EMPLOYER: Entrada Therapeutics Inc LOCATION: Boston, MA (unspecified) SALARY: $127K-$166K POSTED: 2026-05-08 PARENTAL_LEAVE_WEEKS: 0 (not source-backed) K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/entradatherapeutics/jobs/5132958007 EXCERPT: Manager, Market Intelligence and Strategy Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are interested in working at the intersection of life sciences and business. You want to join a high --- TITLE: Veeva RIM Specialist EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Veeva-RIM-Specialist_R2843 EXCERPT: Veeva RIM Specialist Summit, NJ posted: Posted 30+ Days Ago --- TITLE: Information Security Lead EMPLOYER: Click Therapeutics LOCATION: New York, NY (unspecified) SALARY: $130K-$200K POSTED: 2026-02-25 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8414783002 EXCERPT: Information Security Lead New York, NY Who We Are: Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As Information Security Lead, you'll be at the forefront of safeguarding our groundbreaking digital therapeutics. We're seeking an individual with deep technical expertise in information security in the healthcare sector, ready to tackle complex challenges and pioneer innovative solutions. This isn't just a role; it's an opportunity to build, mentor, and inspire a high-performing team, while strategically collaborating across --- TITLE: Technician, Maintenance EMPLOYER: Adient PLC LOCATION: Adient & Summit Banpho (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://adient.wd3.myworkdayjobs.com/External/job/Adient--Summit-Banpho/Technician--Maintenance_R-21032 EXCERPT: Technician, Maintenance Adient & Summit Banpho posted: Posted 30+ Days Ago --- TITLE: Vice President, Pharmaceutical Development EMPLOYER: Kymera Therapeutics Inc LOCATION: Watertown, MA (unspecified) SALARY: $315K-$395K POSTED: 2026-05-26 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.kymeratx.com/careers-culture/working-at-kymera/?gh_jid=7748334003#open-positions EXCERPT: Vice President, Pharmaceutical Development Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: - Define and lead the company's pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines - Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs - Champion innovation in formulation sciences and enabling technologies to --- TITLE: Supervisor, Production EMPLOYER: Adient PLC LOCATION: Adient & Summit Banpho (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://adient.wd3.myworkdayjobs.com/External/job/Adient--Summit-Banpho/Supervisor--Production_R-13361 EXCERPT: Supervisor, Production Adient & Summit Banpho posted: Posted 30+ Days Ago --- TITLE: Site Management Leader (SML) EMPLOYER: Tango Therapeutics Inc LOCATION: Boston, MA (unspecified) SALARY: $128K-$192K POSTED: 2026-05-08 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/tangotherapeutics/jobs/7725413003 EXCERPT: Site Management Leader (SML) Boston, MA Company Overview Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts. Summary We are seeking a Site Management Leader (SML) to oversee all site management and monitoring activities conducted by the CRO in a clinical trial. This role will be assigned to critical clinical trials of the Tango portfolio and serve as the primary contact between sponsor and CRO for site management aspects. In a fast-paced, small biotech environment, the SML will operationally oversee and manage the end-to-end site management activities as per approved timelines, budget, regulatory requirements, and internal standards. This individual will play a key role in the execution and delivery of clinical trial objectives. The ideal candidate is highly collaborative, detail-oriented, and comfortable operating in a hands-on environment, with a focus on building scalable processes, tools, and best practices to support efficient and compliant clinical trial execution. Your role - Serve as the primary liaison --- TITLE: Regulatory Documentation Specialist III EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Regulatory-Documentation-Specialist-III_R2864 EXCERPT: Regulatory Documentation Specialist III Summit, NJ posted: Posted 30+ Days Ago --- TITLE: Patient Access Navigator EMPLOYER: Cogent Biosciences Inc LOCATION: Waltham, Massachusetts, United States (unspecified) SALARY: $170K-$200K POSTED: 2026-03-02 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4163457009 EXCERPT: Patient Access Navigator Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: Cogent Biosciences is searching for compassionate and highly motivated Patient Access Navigators to establish the inaugural Patient Services team. The Patient Access Navigators will be responsible for delivering a high-touch, patient-centered access experience across the prescription fulfillment journey. The Patient Access Navigator will own the end-to-end patient experience within an assigned geographic region and partners closely with patients, caregivers, healthcare providers (HCPs), specialty pharmacies, internal field teams, and external patient services partners to ensure timely access to therapy and continuity of care. While primarily remote/office-based (depending on location), the Patient Access Navigator will support limited non-promotional on-site visits to HCP offices, when appropriate, to support complex access, reimbursement or care coordination needs. The successful candidate will --- TITLE: Associate Director, Health Authorities EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Associate-Director--Health-Authorities_R2915-1 EXCERPT: Associate Director, Health Authorities Summit, NJ posted: Posted 30+ Days Ago --- TITLE: Associate Director, Pipeline & Portfolio Market Planning EMPLOYER: Corcept Therapeutics LOCATION: Redwood City, California, United States (unspecified) SALARY: $215K-$253K POSTED: 2026-04-27 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=5982908004 EXCERPT: Associate Director, Pipeline & Portfolio Market Planning Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Associate Director, Pipeline and Portfolio Market Planning is accountable for developing product strategies across Corcept's oncology portfolio. This individual will guide indication selection and sequencing, competitive landscape assessments, target product profiles (TPPs), product proposition, and long-range financial forecasting to inform program-level decision-making . Responsibilities: - Lead program-level strategy initiatives to define product vision, optimize lifecycle value, and drive business impact - Provide integrated physician, patient, and payer perspective in clinical strategy and new product planning initiatives - Own the design, implementation, and continuous refinement of competitive intelligence and market analysis frameworks that proactively inform program, investment, and governance decisions - Support cross-functional teams, including Commercial, Medical, Development, and Research, to ensure alignment and strategic continuity across the product lifecycle - Develop, maintain, and communicate long-range revenue forecasts and valuation models to support program planning --- TITLE: Regulatory Documentation Specialist II EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Regulatory-Documentation-Specialist-II_R2867 EXCERPT: Regulatory Documentation Specialist II Summit, NJ posted: Posted 30+ Days Ago --- TITLE: ECQ Engineer EMPLOYER: Bristol Myers Squibb LOCATION: Summit West - NJ - US (unspecified) SALARY: Not disclosed POSTED: 2026-06-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Summit-West---NJ---US/ECQ-Engineer_R1603360 EXCERPT: ECQ Engineer Summit West - NJ - US posted: Posted Today --- TITLE: Sr. Analyst/Manager, Access, Policy and Commercial Operations EMPLOYER: Click Therapeutics LOCATION: New York, NY (unspecified) SALARY: $125K-$180K POSTED: 2026-04-29 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8526277002 EXCERPT: Sr. Analyst/Manager, Access, Policy and Commercial Operations New York, NY Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: The Senior Associate provides foundational execution and analytical support across access, policy, and commercial operations. This role is ideal for candidates early in their careers who are eager to build expertise, take on increasing responsibility, and use AI-driven tools to work smarter and faster. This position is based out of Click's headquarters located in --- TITLE: Senior Director, Pharmaceutical Strategy and Development Leader EMPLOYER: Crinetics Pharmaceuticals INC LOCATION: San Diego, CA (unspecified) SALARY: $214K-$268K POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://crinetics.wd12.myworkdayjobs.com/CrineticsCareers/job/San-Diego-CA/Senior-Director--Pharmaceutical-Strategy-and-Development-Leader_JR000446 EXCERPT: Senior Director, Pharmaceutical Strategy and Development Leader San Diego, CA Crinetics is a pharmaceutical company based in San Diego, California that develops much-needed therapies for people with rare endocrine diseases. We were founded by a dedicated team of scientists with the simple belief that better therapies developed from rigorous innovation can lead to better lives. Our work continues to make a real difference in the lives of patients. We have a prolific discovery engine and robust pipeline across preclinical and clinical development. We are driven by science with a patient-centric and team-oriented culture. This is an exciting time to join Crinetics as we shape our organization into the world's premier fully integrated endocrine company from discovery to patients. Come join our team as we transform the lives of others. Position Summary: The Senior Director, Pharmaceutical Development Team Leader (PDTL) is responsible for developing and leading the execution of comprehensive, compound-specific Technical Operations strategies to meet the global project team's (GPT) needs. This role provides leadership to interdisciplinary teams, managing multiple assets through various stages of development, and collaborates with various functional areas to achieve optimal development and business results. Essential Job Functions and Responsibilities: These may include but are not limited to: Develop, refine, update, and oversee Technical Operations project plans from multiple inputs, with emphasis on the alignment of these plans with strategic objectives, the decomposition of major objectives into discrete WBS-level work packages, the mapping of internal and cross-functional interdependencies, and the management of project risks. Perform detailed --- TITLE: Senior Specialist, Regulatory Affairs EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Senior-Specialist--Regulatory-Affairs_R2936 EXCERPT: Senior Specialist, Regulatory Affairs Summit, NJ posted: Posted 30+ Days Ago --- TITLE: Manufacturing Associate EMPLOYER: Bristol Myers Squibb LOCATION: Summit West - NJ - US (unspecified) SALARY: Not disclosed POSTED: 2026-06-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Summit-West---NJ---US/Manufacturing-Associate_R1603347 EXCERPT: Manufacturing Associate Summit West - NJ - US posted: Posted Today --- TITLE: Senior Director, Medical Affairs Operations and Strategy EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $269K-$295K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5973783004 EXCERPT: Senior Director, Medical Affairs Operations and Strategy Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! Responsibilities: In collaboration with Medical Affairs leadership, develop, operationalize, and continuously refine the Medical Affairs strategy, helping to translate strategic objectives into actionable project plans, KPIs and timelines Oversee and ensure the quality of the departmental strategic planning processes, including operations tasks, and other activities related to pipeline compounds Leads organization, updating and communication of strategic plans to internal and external stakeholders --- TITLE: Associate Director, Global Pricing Strategy & Analytics EMPLOYER: Revolution Medicines LOCATION: Remote (United States) (remote) SALARY: $177K-$221K POSTED: 2026-04-24 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7714049003 EXCERPT: Associate Director, Global Pricing Strategy & Analytics Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Global Pricing Strategy & Analytics will play a critical role in shaping and executing global pricing strategies across the portfolio. This individual will lead the development of pricing frameworks, provide advanced analytics, and generate insights to support value optimization and market access decisions. The role requires strong cross-functional collaboration with Market Access, Commercial, Finance, HEOR, and Regional teams to ensure pricing strategies are aligned with business objectives and external market dynamics. Key Responsibilities: Global Pricing Strategy - Support the development and execution of global pricing strategies for pipeline products across key markets. - Establish pricing guidance, guardrails, and launch sequencing strategies to optimize global value. - Evaluate pricing scenarios considering payer dynamics, competitive landscape, and regulatory constraints. - Support early asset strategy by integrating pricing considerations into clinical and commercial planning. Analytics & Insights - Design and deliver advanced --- TITLE: Technician I - TSDF EMPLOYER: Republic Services LOCATION: Browns Summit, NC, USA (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://republic.wd5.myworkdayjobs.com/republic/job/Browns-Summit-NC-USA/Technician-I---TSDF_R-171390 EXCERPT: Technician I - TSDF Browns Summit, NC, USA posted: Posted 30+ Days Ago --- TITLE: Associate Director, Analytical Sciences and Attribute Characterization EMPLOYER: Spyre Therapeutics Inc LOCATION: US- Remote (remote) SALARY: $175K-$190K POSTED: 2026-05-27 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/spyretherapeutics/jobs/5231284008 EXCERPT: Associate Director, Analytical Sciences and Attribute Characterization US- Remote Spyre Therapeutics is a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23. Role Summary: The Associate Director, Analytical Sciences and Attribute Characterization, oversees structural and functional characterization and comparability studies across Spyre's clinical and late-stage mAb and mAb-mAb combination programs. This role is a key leader within the Analytical Development and Quality Control (ADQC) organization and reports directly to the Vice President. The position provides both strategic and operational leadership for analytical characterization and comparability, in close collaboration with internal process, analytical, and regulatory teams, as well as global CDMO partners. The Associate Director defines phase-appropriate characterization and comparability strategies that support formulation, process, and analytical development, quality control, and regulatory submissions, aligned with regulatory expectations and industry best practices. This role drives proactive planning to ensure efficient advancement of drug candidates through clinical development stages. Key Responsibilities: - Provide strategic and technical leadership for multidimensional biologics characterization to support product understanding and comparability in a phase-appropriate manner, enabling regulatory submissions for clinical development through BLA & MAA, primarily executed through global CDMO partners. - Serve as subject matter expert (SME) in mAb and mAb-mAb combination product molecular characterization and comparability, applying a fit-for-purpose suite of biochemical, biophysical, physicochemical, and functional assays (e.g., advanced mass spectrometry, capillary and --- TITLE: Strategy Manager EMPLOYER: Home Depot (The) LOCATION: SMYRNA PACES SUMMIT - 9125 (unspecified) SALARY: Not disclosed POSTED: 2026-05-27 PARENTAL_LEAVE_WEEKS: 6 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://homedepot.wd5.myworkdayjobs.com/CareerDepot/job/SMYRNA-PACES-SUMMIT---9125/Strategy-Manager_Req176102 EXCERPT: Strategy Manager SMYRNA PACES SUMMIT - 9125 posted: Posted 16 Days Ago --- TITLE: The Summit Federal Credit Union EMPLOYER: LPL Financial LOCATION: Syracuse, NY (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://lplfinancial.wd1.myworkdayjobs.com/BD_Partners/job/Syracuse-NY/The-Summit-Federal-Credit-Union_R-047082 EXCERPT: The Summit Federal Credit Union Syracuse, NY posted: Posted 30+ Days Ago --- TITLE: PRN ECT RN EMPLOYER: Summit BHC LOCATION: Peak View Behavioral Health (unspecified) SALARY: Not disclosed POSTED: 2026-05-26 APPLY_URL: https://summitbhc.wd1.myworkdayjobs.com/Summit_BHC/job/Peak-View-Behavioral-Health/PRN-ECT-RN_JR124970 EXCERPT: PRN ECT RN Peak View Behavioral Health posted: Posted 17 Days Ago --- TITLE: Director, Product and Pipeline Communications (Endocrinology and Metabolic) EMPLOYER: Corcept Therapeutics LOCATION: Redwood City, California, United States (unspecified) SALARY: $239K-$281K POSTED: 2026-06-10 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=6019134004 EXCERPT: Director, Product and Pipeline Communications (Endocrinology and Metabolic) Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Director of Product and Pipeline Communications will drive product communications initiatives and activities across a growing roster of therapeutic areas for our Endocrinology business and metabolic disease program. Reporting to the Senior Director of Corporate Communications, the Director of Product and Pipeline Communications will drive initiatives that support increased product awareness and bolster Corcept's corporate reputation, developing approaches to communication that improve engagement with external stakeholders and meet the evolving business needs of the organization. Responsibilities: - Partner with leaders throughout the organization to plan and execute strategic communications activities to raise visibility of our products and pipeline - Develop and implement communications plans leveraging earned media, sponsored content, social media and owned media channels to engage and inform media, investors, employees, healthcare professionals, consumers, policymakers, advocacy partners and other external stakeholders - --- TITLE: Regulatory Affairs Program Manager EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-21 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Regulatory-Affairs-Program-Manager_R2768 EXCERPT: Regulatory Affairs Program Manager Summit, NJ posted: Posted 22 Days Ago --- TITLE: Senior Scientist, Regulatory CMC EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Senior-Scientist--Regulatory-CMC_R2871 EXCERPT: Senior Scientist, Regulatory CMC Summit, NJ posted: Posted 30+ Days Ago --- TITLE: Senior Director, Clinical Pharmacology EMPLOYER: Nuvalent Inc LOCATION: Cambridge, MA / Remote (remote) SALARY: $270K-$295K POSTED: 2026-03-24 APPLY_URL: https://boards.greenhouse.io/nuvalent/jobs/5835506004?gh_jid=5835506004 EXCERPT: Senior Director, Clinical Pharmacology Cambridge, MA / Remote The Company: With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building. The Role: The Senior Director, Clinical Pharmacology will lead Nuvalent's clinical pharmacology strategy across all development programs, including late‑stage registrational efforts and emerging early‑phase assets. This leader will guide dose optimization, exposure-response modeling, regulatory strategy, and clinical pharmacology components of NDA submissions. Responsibilities: - Serve as the clinical pharmacology lead and develop and execute strategies to support Phase 1, registrational, and post‑marketing studies, including designing and leading clinical pharmacology studies. - Drive the integration of PK, PD, safety, and efficacy data to inform dose selection, dose modification, and labeling recommendations. - Lead clinical pharmacology contributions to INDs, CTAs, IBs, and NDA submissions. - Represent clinical pharmacology in interactions with FDA and other global regulators, supporting discussions related to dose justification, pediatric waivers, safety margins, and DDI strategies. - Partner closely with DMPK, Non-clinical Toxicology, Clinical Development, Biostatistics, CMC, and Regulatory Affairs to ensure cohesive end‑to‑end development plans. - Oversee population PK modeling, PK/PD modeling, and exposure-response analyses for efficacy and safety. - Guide quantitative pharmacology approaches supporting optimal dosing in patients. - Build and mentor a growing clinical pharmacology function as Nuvalent transitions from clinical‑stage to commercial‑ - Contribute to --- TITLE: Principal Scientist, Regulatory CMC EMPLOYER: Immunitybio Inc LOCATION: Summit, NJ (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://nant.wd5.myworkdayjobs.com/ImmunityBio/job/Summit-NJ/Principal-Scientist--Regulatory-CMC_R2870 EXCERPT: Principal Scientist, Regulatory CMC Summit, NJ posted: Posted 30+ Days Ago --- TITLE: DTx Quality Engineer (6 Month Contract) EMPLOYER: Click Therapeutics LOCATION: Remote (remote) SALARY: $100-$120/hr POSTED: 2026-05-04 APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8534499002 EXCERPT: DTx Quality Engineer (6 Month Contract) Remote Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. Responsibilities: - Initiate and manage complaint records for investigational and commercial SaMD applications from receipt to closure in a timely and compliant manner. - Maintain all records in a state of audit readiness ensuring compliance with internal procedures and applicable regulatory requirements. - Evaluate incoming complaint information on whether reporting to applicable government agencies is required. - Coordinate with cross-functional --- TITLE: Associate Director, Digital & Commercial Analytics EMPLOYER: Corcept Therapeutics LOCATION: Redwood City, California, United States (unspecified) SALARY: $215K-$253K POSTED: 2026-04-29 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=5983868004 EXCERPT: Associate Director, Digital & Commercial Analytics Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . Corcept Oncology is seeking an experienced and collaborative Associate Director, Digital & Commercial Analytics to lead next best action (NBA) orchestration and advanced analytics across marketing, and market access domains. This individual will co-lead the design, deployment, and monitoring of next best action (NBA) orchestration and deliver high-impact analytics across marketing performance, digital engagement, and market access. This role will work in close partnership with Digital Marketing, Commercial Operations, Market Access, IT, and external partners. The ideal candidate brings strong experience in data-driven decisioning and orchestration platforms (e.g., Salesforce Marketing Cloud, CRM) and has operated in complex, matrixed commercial environments. While pharmaceutical experience is preferred, we are open to candidates from other industries with demonstrated expertise in decision sciences, personalization, and digital analytics. Responsibilities: Next Best Action (NBA) Strategy & Orchestration - Co-lead the design, implementation, --- TITLE: Senior Data Solution Architect/Engineer EMPLOYER: Land O'Lakes, Inc. LOCATION: Gray Summit, Missouri, United States of America (unspecified) SALARY: Not disclosed POSTED: 2026-06-09 K401_MATCH: yes (not source-backed) APPLY_URL: https://landolakes.wd1.myworkdayjobs.com/LandOLakes/job/Gray-Summit-MO-USA/Senior-Data-Solution-Architect-Engineer_R-39242/apply EXCERPT: Senior Data Solution Architect/Engineer Gray Summit, Missouri, United States of America Senior Data Solution Architect/Engineer. Position Description. Senior Data Solution Architect/Engineer for Land O'Lakes, Inc., Gray Summit, MO. Engineer Purina Animal Nutrition Data Analytics platform... --- TITLE: Director, Pharmacovigilance Operations and Engagement EMPLOYER: Corcept Therapeutics LOCATION: Redwood City, California, United States (unspecified) SALARY: $240K-$280K POSTED: 2026-02-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=5790809004 EXCERPT: Director, Pharmacovigilance Operations and Engagement Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . This will serve as the PSPV lead for cross-functional activities and commercial initiatives, ensuring successful product launch and lifecycle management with patient safety integrated throughout the organization. This highly visible role will act as a strategic partner to Medical Affairs, Quality, Legal, and Commercial teams, driving operational and compliance excellence across all touchpoints. This is a hybrid role typically requiring on-site presence at least 3 days per week at company headquarters in Redwood City. Responsibilities: Cross-Functional Leadership & Collaboration: - Build strategic partnerships and alignment of patient safety objectives and deliverables with internal stakeholders (Medical Affairs, Quality, Legal, Commercial) and external vendors/partners - Establish and lead cross functional governance forum with PSPV, Medical Affairs, Quality, Legal, Commercial to review all commercial initiatives/activities for cross functional planning and execution - Act as the Safety Lead for implementation and --- TITLE: CAD Specialist EMPLOYER: Adient PLC LOCATION: Adient&Summit Corp. Ltd.-Trim (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://adient.wd3.myworkdayjobs.com/External/job/AdientSummit-Corp-Ltd-Trim/CAD-Specialist_R-14181 EXCERPT: CAD Specialist Adient&Summit Corp. Ltd.-Trim posted: Posted 30+ Days Ago --- TITLE: Director, Thought Leader Liaisons EMPLOYER: Corcept Therapeutics LOCATION: Redwood City, California, United States (unspecified) SALARY: $191K-$253K POSTED: 2026-06-05 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=6015489004 EXCERPT: Director, Thought Leader Liaisons Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Director, Thought Leader Liaisons is responsible for national leadership, strategic planning, and execution excellence for Corcept's TLL organization. This team engages thought leaders across endocrinology, diabetology, cardiology, nephrology, radiology, endocrine surgery, and other specialties to advance disease-state awareness, scientific education, and clinical insight generation. The Director partners extensively with Key Account Managers (KAMs), Clinical Specialists (CSs), Medical Science Liaisons (MSLs), Marketing, Field Medical, and Medical Affairs to ensure coordinated execution, consistent scientific engagement, and strong alignment with organizational priorities. Responsibilities: Strategic Leadership & Team Development - Lead, coach, and develop a high-performing national TLL team grounded in scientific excellence and collaboration - Establish strategic priorities, objectives, and KPIs aligned to corporate goals - Strengthen capabilities in scientific exchange, KOL engagement, insight capture, meeting facilitation, and peer-level clinical discussion - Ensure consistent field standards and best practices National --- TITLE: Electrical Technician EMPLOYER: The Procter & Gamble Company LOCATION: GREENSBORO BROWN SUMMIT PLANT (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 PARENTAL_LEAVE_WEEKS: 8 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 8 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://pg.wd5.myworkdayjobs.com/1000/job/GREENSBORO-BROWN-SUMMIT-PLANT/Electrical-Technician_R000135713 EXCERPT: Electrical Technician GREENSBORO BROWN SUMMIT PLANT posted: Posted 30+ Days Ago --- TITLE: Executive Director, Clinical Supply Chain EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $265K-$331K POSTED: 2026-04-10 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695198003 EXCERPT: Executive Director, Clinical Supply Chain Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Executive Director, Clinical Supply Chain provides strategic leadership and operational oversight for end-to-end clinical supply chain activities across the organization. Strategic Leadership - Define and execute the global clinical supply chain strategy aligned with the company's clinical development pipeline and long-term business goals. - Establishes strategies and processes to ensure uninterrupted supply for Revolution Medicines portfolio across all phases of development. - Lead and serve as subject matter expert for clinical supply chain planning, risk management, and execution of clinical supply chain activities. - Build scalable processes and infrastructure to support early- through late-phase clinical programs. - Strategic Planning on comparator sourcing management to ensure timely, compliant and cost-effective product availability. - Effective management of clinical studies executed in conjunction with collaboration partners. - Identify and implement overall clinical supply chain best practices. Clinical Supply Operations - Oversee end-to-end clinical supply --- TITLE: Elevate at Ecolab, 2026 Development Summit EMPLOYER: Ecolab LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-09 PARENTAL_LEAVE_WEEKS: 6 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://ecolab.wd1.myworkdayjobs.com/Ecolab_External/job/USA---Minnesota---Saint-Paul/Elevate-at-Ecolab--2026-Development-Summit_R00295438 EXCERPT: Elevate at Ecolab, 2026 Development Summit 2 Locations posted: Posted 3 Days Ago --- TITLE: Maintenance Specialist EMPLOYER: Bristol Myers Squibb LOCATION: Summit West - NJ - US (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Summit-West---NJ---US/Maintenance-Specialist_R1602101 EXCERPT: Maintenance Specialist Summit West - NJ - US posted: Posted 30+ Days Ago --- TITLE: Senior Director/Executive Director, DMPK EMPLOYER: Iambic Therapeutics LOCATION: San Diego HQ, San Diego, California, United States (unspecified) SALARY: Not disclosed POSTED: 2026-05-13 K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.ashbyhq.com/iambic-therapeutics/416f46b9-e8f1-44e7-8749-590ee26e6d52 EXCERPT: Senior Director/Executive Director, DMPK San Diego HQ, San Diego, California, United States JOB SUMMARY Iambic Therapeutics is seeking an experienced DMPK leader to lead our Drug Metabolism & Pharmacokinetics function. Reporting to senior leadership, you will define the scientific strategy for DMPK from early discovery through IND-enabling studies. You will collaborate with internal and external partners to plan and execute DMPK studies. This is a high-impact, hands-on leadership role for someone who thrives at the intersection of rigorous science and strategic drug development. KEY RESPONSIBILITIES - Lead and manage all DMPK strategy and execution across Iambic's discovery programs, setting clear goals and ensuring alignment with cross-functional program teams. - Design and oversee non-clinical ADME/PK studies and PK/PD modeling to enable candidate selection and accelerate IND filings. - Serve as the internal DMPK subject matter expert, partnering with medicinal chemistry, biology, toxicology, and clinical teams to interpret data and guide program decisions. - Build and manage a high-performing network of CRO partners and academic collaborators to supplement internal capabilities. - Lead preparation and review of DMPK sections for regulatory submissions including INDs and NDAs; interact with health authorities as needed. - Champion compliance with ICH guidelines, FDA regulations, and industry best practices across all DMPK activities. - Contribute scientific expertise to business development, due diligence, and partnership evaluations. - Stay at the forefront of emerging DMPK science, technologies, and regulatory trends to continuously strengthen the function. QUALIFICATIONS - PhD in Pharmacokinetics, Pharmaceutical Sciences, or closely related discipline or PharmD - 12+ --- TITLE: Associate Director, Global Drug Substance Commercialization, Critical Raw Materials EMPLOYER: Vaxcyte Inc LOCATION: San Carlos, California, United States (unspecified) SALARY: $174K-$203K POSTED: 2025-11-07 K401_MATCH: yes (not source-backed) APPLY_URL: https://boards.greenhouse.io/vaxcyte/jobs/4974572008?gh_jid=4974572008 EXCERPT: Associate Director, Global Drug Substance Commercialization, Critical Raw Materials San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Associate Director for Drug Substance (DS) Commercialization has the accountability for launch readiness and commercial supply of associated raw materials for production of eCRM and associated components for glycoconjugate vaccines. This role focuses on technical launch planning and execution by bringing best-practices and coordinating cross-functional efforts --- [PASTE YOUR RESUME OR SKILLS HERE]